Logo
x

Search

Subscribe Now

Ad26.COV2.S

J&J’s Vaccine Booster Dose Increases Antibody & T-cell Responses 6 mos Post BNT162B2 Regimen

J&J’s Vaccine Booster Dose Increases Antibody & T-cell Responses 6 mos Post BNT162B2 Regimen

  • December 6, 2021
J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine

J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine

  • September 24, 2020
Johnson & Johnson Collaborates with the Government of Canada to Supply its Ad26.COV2.S for COVID-19

Johnson & Johnson Collaborates with the Government of Canada to Supply its Ad26.COV2.S for COVID-19

  • September 1, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.